{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:00:24Z","timestamp":1792594824395,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Oxidative stress and advanced glycation end products (AGEs) could promote vascular aging in type 2 diabetes mellitus (T2DM), but their relationship with glycemic variability remains unclear. We conducted a cross-sectional study of 68 patients with T2DM who underwent continuous glucose monitoring (CGM). Short-, intermediate-, and long-term glycemic variability were assessed using the % coefficient of variation of glucose (%CV), mean of daily differences (MODD), and HbA1c variability over the prior 2\u00a0years, respectively. Oxidative stress was measured by the diacron-reactive oxygen metabolites (d-ROMs) test, and AGE accumulation by skin autofluorescence (SAF). Multivariate analyses identified female sex, %CV, MODD, and nephropathy stage as independent correlates of d-ROMs (adjusted R\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u20090.436). Duration of diabetes, MODD, urinary albumin-to-creatinine ratio, and macroangiopathy were independently associated with SAF (adjusted R\n                    <jats:sup>2<\/jats:sup>\n                    \u2009=\u20090.265). This study suggests that short- and intermediate-term glycemic variability correlate with oxidative stress and AGE accumulation, which may be associated with vascular complications in T2DM.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-31845-x","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T17:48:20Z","timestamp":1765475300000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Association of glycemic variability with oxidative stress and AGE accumulation in type 2 diabetes"],"prefix":"10.1038","volume":"16","author":[{"given":"Makoto","family":"Ohara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Takehana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Osaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroe","family":"Sugita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michishige","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusaku","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyasu","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho-ichi","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"key":"31845_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.arr.2008.07.002","volume":"8","author":"HY Chung","year":"2009","unstructured":"Chung, H. Y. et al. Molecular inflammation: underpinnings of aging and age-related diseases. Ageing Res Rev. 8, 18\u201330. https:\/\/doi.org\/10.1016\/j.arr.2008.07.002 (2009).","journal-title":"Ageing Res Rev."},{"key":"31845_CR2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1445-5994.2012.02758.x","volume":"42","author":"G Cheng","year":"2012","unstructured":"Cheng, G., Huang, C., Deng, H. & Wang, H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern. Med. J. 42, 484\u2013491. https:\/\/doi.org\/10.1111\/j.1445-5994.2012.02758.x (2012).","journal-title":"Intern. Med. J."},{"key":"31845_CR3","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1007\/s00125-014-3369-7","volume":"57","author":"S Zoungas","year":"2014","unstructured":"Zoungas, S. et al. Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes. Diabetologia 57, 2465\u20132474. https:\/\/doi.org\/10.1007\/s00125-014-3369-7 (2014).","journal-title":"Diabetologia"},{"key":"31845_CR4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/CIA.S158513","volume":"13","author":"I Liguori","year":"2018","unstructured":"Liguori, I. et al. Oxidative stress, aging, and diseases. Clin. Interv. Aging. 13, 757\u2013772. https:\/\/doi.org\/10.2147\/CIA.S158513 (2018).","journal-title":"Clin. Interv. Aging."},{"key":"31845_CR5","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","volume":"153","author":"C L\u00f3pez-Ot\u00edn","year":"2013","unstructured":"L\u00f3pez-Ot\u00edn, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194\u20131217. https:\/\/doi.org\/10.1016\/j.cell.2013.05.039 (2013).","journal-title":"Cell"},{"key":"31845_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cmet.2018.08.014","volume":"28","author":"J Chaudhuri","year":"2018","unstructured":"Chaudhuri, J. et al. The role of advanced glycation end products in aging and metabolic diseases: bridging association and causality. Cell Metab. 28, 337\u2013352. https:\/\/doi.org\/10.1016\/j.cmet.2018.08.014 (2018).","journal-title":"Cell Metab."},{"key":"31845_CR7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1089\/rej.2012.1335","volume":"15","author":"S Yamagishi","year":"2012","unstructured":"Yamagishi, S. Potential clinical utility of advanced glycation end product cross-link breakers in aging- and diabetes-associated disorders. Rejuvenation Res. 15, 564\u2013572. https:\/\/doi.org\/10.1089\/rej.2012.1335 (2012).","journal-title":"Rejuvenation Res."},{"key":"31845_CR8","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"Brownlee, M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54, 1615\u20131625. https:\/\/doi.org\/10.2337\/diabetes.54.6.1615 (2005).","journal-title":"Diabetes"},{"key":"31845_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton, I. M. et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321, 405\u2013412. https:\/\/doi.org\/10.1136\/bmj.321.7258.405 (2000).","journal-title":"BMJ"},{"issue":"Suppl 2","key":"31845_CR10","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.2337\/dc08-s241","volume":"31","author":"L Monnier","year":"2008","unstructured":"Monnier, L. & Colette, C. Glycemic variability: should we and can we prevent it?. Diabetes Care 31(Suppl 2), S150\u2013S154. https:\/\/doi.org\/10.2337\/dc08-s241 (2008).","journal-title":"Diabetes Care"},{"key":"31845_CR11","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","volume":"295","author":"L Monnier","year":"2006","unstructured":"Monnier, L. et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295, 1681\u20131687. https:\/\/doi.org\/10.1001\/jama.295.14.1681 (2006).","journal-title":"JAMA"},{"key":"31845_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2337\/diacare.19.3.257","volume":"19","author":"D Giugliano","year":"1996","unstructured":"Giugliano, D., Ceriello, A. & Paolisso, G. Oxidative stress and diabetic vascular complications. Diabetes Care 19, 257\u2013267. https:\/\/doi.org\/10.2337\/diacare.19.3.257 (1996).","journal-title":"Diabetes Care"},{"key":"31845_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12933-020-01085-6","volume":"19","author":"Z Zhou","year":"2020","unstructured":"Zhou, Z., Sun, B., Huang, S., Zhu, C. & Bian, M. Glycemic variability: adverse clinical outcomes and how to improve it?. Cardiovasc. Diabetol. 19, 102. https:\/\/doi.org\/10.1186\/s12933-020-01085-6 (2020).","journal-title":"Cardiovasc. Diabetol."},{"key":"31845_CR14","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Intensive blood\u2013glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837\u2013853. https:\/\/doi.org\/10.1016\/S0140-6736(98)07019-6 (1998).","journal-title":"Lancet"},{"key":"31845_CR15","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/nejmoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R. & Neil, H. A. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 359, 1577\u20131589. https:\/\/doi.org\/10.1056\/nejmoa0806470 (2008).","journal-title":"N. Engl. J. Med."},{"key":"31845_CR16","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/nejmoa0802743","volume":"358","author":"HC Gerstein","year":"2008","unstructured":"Action to Control Cardiovascular Risk in Diabetes Study Group et al. Effects of intensive glucose lowering in type 2 diabetes. N. Engl. J. Med. 358, 2545\u20132559. https:\/\/doi.org\/10.1056\/nejmoa0802743 (2008).","journal-title":"N. Engl. J. Med."},{"key":"31845_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/nejmoa0808431","volume":"360","author":"W Duckworth","year":"2009","unstructured":"Duckworth, W. et al. Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 360, 129\u2013139. https:\/\/doi.org\/10.1056\/nejmoa0808431 (2009).","journal-title":"N. Engl. J. Med."},{"key":"31845_CR18","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/circresaha.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco, F. & Brownlee, M. Oxidative stress and diabetic complications. Circ. Res. 107, 1058\u20131070. https:\/\/doi.org\/10.1161\/circresaha.110.223545 (2010).","journal-title":"Circ. Res."},{"key":"31845_CR19","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.2337\/dc19-0292","volume":"42","author":"Y Xuan","year":"2019","unstructured":"Xuan, Y. et al. Association of serum markers of oxidative stress with incident major cardiovascular events, cancer incidence, and all-cause mortality in type 2 diabetes patients: pooled results from two cohort studies. Diabetes Care 42, 1436\u20131445. https:\/\/doi.org\/10.2337\/dc19-0292 (2019).","journal-title":"Diabetes Care"},{"key":"31845_CR20","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1253\/circj.cj-19-0618","volume":"83","author":"SI Yamagishi","year":"2019","unstructured":"Yamagishi, S. I. Role of advanced glycation endproduct (AGE)-receptor for advanced glycation endproduct (RAGE) axis in cardiovascular disease and its therapeutic intervention. Circ. J. 83, 1822\u20131828. https:\/\/doi.org\/10.1253\/circj.cj-19-0618 (2019).","journal-title":"Circ. J."},{"key":"31845_CR21","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","volume":"47","author":"R Meerwaldt","year":"2004","unstructured":"Meerwaldt, R. et al. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 47, 1324\u20131330. https:\/\/doi.org\/10.1007\/s00125-004-1451-2 (2004).","journal-title":"Diabetologia"},{"key":"31845_CR22","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2337\/dc07-1755","volume":"31","author":"EG Gerrits","year":"2008","unstructured":"Gerrits, E. G. et al. Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications. Diabetes Care 31, 517\u2013521. https:\/\/doi.org\/10.2337\/dc07-1755 (2008).","journal-title":"Diabetes Care"},{"key":"31845_CR23","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.2337\/dc05-2173","volume":"29","author":"HL Lutgers","year":"2006","unstructured":"Lutgers, H. L. et al. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care 29, 2654\u20132659. https:\/\/doi.org\/10.2337\/dc05-2173 (2006).","journal-title":"Diabetes Care"},{"key":"31845_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ijcard.2015.03.167","volume":"185","author":"S Yamagishi","year":"2015","unstructured":"Yamagishi, S., Fukami, K. & Matsui, T. Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: A novel marker of vascular complications in high-risk patients for cardiovascular disease. Int. J. Cardiol. 185, 263\u2013268. https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.167 (2015).","journal-title":"Int. J. Cardiol."},{"key":"31845_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijcard.2022.03.001","volume":"354","author":"Y Hitomi","year":"2022","unstructured":"Hitomi, Y. et al. Effectiveness of the d-ROMs oxidative stress test to predict long-term cardiovascular mortality. Int. J. Cardiol. 354, 43\u201347. https:\/\/doi.org\/10.1016\/j.ijcard.2022.03.001 (2022).","journal-title":"Int. J. Cardiol."},{"key":"31845_CR26","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.3390\/antiox11081541","volume":"11","author":"F Pigazzani","year":"2022","unstructured":"Pigazzani, F. et al. The prognostic value of derivatives-reactive oxygen metabolites (d-ROMs) for cardiovascular disease events and mortality: a review. Antioxidants (Basel). 11, 1541. https:\/\/doi.org\/10.3390\/antiox11081541 (2022).","journal-title":"Antioxidants (Basel)."},{"key":"31845_CR27","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ijcard.2016.07.225","volume":"222","author":"N Masaki","year":"2016","unstructured":"Masaki, N. et al. Usefulness of the d-ROMs test for prediction of cardiovascular events. Int. J. Cardiol. 222, 226\u2013232. https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.225 (2016).","journal-title":"Int. J. Cardiol."},{"key":"31845_CR28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.5551\/jat.56069","volume":"28","author":"K Sasaki","year":"2021","unstructured":"Sasaki, K. et al. Oxidative stress and inflammation as predictors of mortality and cardiovascular events in hemodialysis patients: the DREAM cohort. J. Atheroscler. Thromb. 28, 249\u2013260. https:\/\/doi.org\/10.5551\/jat.56069 (2021).","journal-title":"J. Atheroscler. Thromb."},{"key":"31845_CR29","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10654-018-0457-x","volume":"34","author":"Y Xuan","year":"2019","unstructured":"Xuan, Y. et al. Association of serum markers of oxidative stress with myocardial infarction and stroke: pooled results from four large European cohort studies. Eur. J. Epidemiol. 34, 471\u2013481. https:\/\/doi.org\/10.1007\/s10654-018-0457-x (2019).","journal-title":"Eur. J. Epidemiol."},{"key":"31845_CR30","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.3390\/jcm12175731","volume":"12","author":"M Costantino","year":"2023","unstructured":"Costantino, M. et al. Marked reduction of oxidant species after sulfureous crenotherapy in females with joint diseases and psoriasis: a retrospective real-life study. J Clin Med 12, 5731. https:\/\/doi.org\/10.3390\/jcm12175731 (2023).","journal-title":"J Clin Med"},{"key":"31845_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.diabres.2016.09.025","volume":"122","author":"M Ohara","year":"2016","unstructured":"Ohara, M. et al. Relationship between daily and day-to-day glycemic variability and increased oxidative stress in type 2 diabetes. Diabetes Res. Clin. Pract. 122, 62\u201370. https:\/\/doi.org\/10.1016\/j.diabres.2016.09.025 (2016).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"31845_CR32","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.2337\/diabetes.52.11.2795","volume":"52","author":"L Quagliaro","year":"2003","unstructured":"Quagliaro, L. et al. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 52, 2795\u20132804. https:\/\/doi.org\/10.2337\/diabetes.52.11.2795 (2003).","journal-title":"Diabetes"},{"key":"31845_CR33","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12933-016-0427-0","volume":"15","author":"N Wu","year":"2016","unstructured":"Wu, N. et al. Acute blood glucose fluctuation enhances rat aorta endothelial cell apoptosis, oxidative stress and pro-inflammatory cytokine expression in vivo. Cardiovasc. Diabetol. 15, 109. https:\/\/doi.org\/10.1186\/s12933-016-0427-0 (2016).","journal-title":"Cardiovasc. Diabetol."},{"key":"31845_CR34","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/dmrr.613","volume":"22","author":"L Piconi","year":"2006","unstructured":"Piconi, L. et al. Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction. Diabetes Metab. Res. Rev. 22, 198\u2013203. https:\/\/doi.org\/10.1002\/dmrr.613 (2006).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"31845_CR35","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/1471-2369-14-191","volume":"14","author":"Y Ishizaka","year":"2013","unstructured":"Ishizaka, Y., Yamakado, M., Toda, A., Tani, M. & Ishizaka, N. Relationship between estimated glomerular filtration rate, albuminuria, and oxidant status in the Japanese population. BMC Nephrol. 14, 191. https:\/\/doi.org\/10.1186\/1471-2369-14-191 (2013).","journal-title":"BMC Nephrol."},{"key":"31845_CR36","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.bbagen.2010.04.011","volume":"1800","author":"S Kumar","year":"2010","unstructured":"Kumar, S., Lata, K., Mukhopadhyay, S. & Mukherjee, T. K. Role of estrogen receptors in pro-oxidative and anti-oxidative actions of estrogens: a perspective. Biochim. Biophys. Acta. 1800, 1127\u20131135. https:\/\/doi.org\/10.1016\/j.bbagen.2010.04.011 (2010).","journal-title":"Biochim. Biophys. Acta."},{"key":"31845_CR37","doi-asserted-by":"publisher","first-page":"644","DOI":"10.2337\/diab.19.9.644","volume":"19","author":"GD Molnar","year":"1970","unstructured":"Service FJ et al. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19, 644\u2013655. https:\/\/doi.org\/10.2337\/diab.19.9.644 (1970).","journal-title":"Diabetes"},{"issue":"Suppl 1","key":"31845_CR38","doi-asserted-by":"publisher","first-page":"S171","DOI":"10.1007\/s00592-012-0398-x","volume":"49","author":"CM Chang","year":"2012","unstructured":"Chang, C. M., Hsieh, C. J., Huang, J. C. & Huang, I. C. Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus. Acta Diabetol. 49(Suppl 1), S171\u2013S177. https:\/\/doi.org\/10.1007\/s00592-012-0398-x (2012).","journal-title":"Acta Diabetol."},{"key":"31845_CR39","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino, T. et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care 42, 1593\u20131603. https:\/\/doi.org\/10.2337\/dci19-0028 (2019).","journal-title":"Diabetes Care"},{"key":"31845_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.15171\/jrip.2017.30","volume":"6","author":"L Mahmoodnia","year":"2017","unstructured":"Mahmoodnia, L., Aghadavod, E., Beigrezaei, S. & Rafieian-Kopaei, M. An update on diabetic kidney disease, oxidative stress and antioxidant agents. J. Renal Inj Prev. 6, 153\u2013157. https:\/\/doi.org\/10.15171\/jrip.2017.30 (2017).","journal-title":"J. Renal Inj Prev."},{"key":"31845_CR41","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12902-020-00676-4","volume":"21","author":"HE Boersma","year":"2021","unstructured":"Boersma, H. E. et al. Skin autofluorescence predicts new cardiovascular disease and mortality in people with type 2 diabetes. BMC Endocr. Disord. 21, 14. https:\/\/doi.org\/10.1186\/s12902-020-00676-4 (2021).","journal-title":"BMC Endocr. Disord."},{"key":"31845_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2337\/dc06-1391","volume":"30","author":"R Meerwaldt","year":"2007","unstructured":"Meerwaldt, R. et al. Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care 30, 107\u2013112. https:\/\/doi.org\/10.2337\/dc06-1391 (2007).","journal-title":"Diabetes Care"},{"key":"31845_CR43","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1172\/jci118175","volume":"96","author":"AM Schmidt","year":"1995","unstructured":"Schmidt, A. M. et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J. Clin. Invest. 96, 1395\u20131403. https:\/\/doi.org\/10.1172\/jci118175 (1995).","journal-title":"J. Clin. Invest."},{"key":"31845_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s10238-009-0074-9","volume":"10","author":"M Tsunosue","year":"2010","unstructured":"Tsunosue, M. et al. An alpha-glucosidase inhibitor, acarbose treatment decreases serum levels of glyceraldehyde-derived advanced glycation end products (AGEs) in patients with type 2 diabetes. Clin. Exp. Med. 10, 139\u2013141. https:\/\/doi.org\/10.1007\/s10238-009-0074-9 (2010).","journal-title":"Clin. Exp. Med."},{"key":"31845_CR45","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1172\/jci119180","volume":"99","author":"ED Schleicher","year":"1997","unstructured":"Schleicher, E. D., Wagner, E. & Nerlich, A. G. Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J. Clin. Invest. 99, 457\u2013468. https:\/\/doi.org\/10.1172\/jci119180 (1997).","journal-title":"J. Clin. Invest."},{"key":"31845_CR46","doi-asserted-by":"publisher","first-page":"100038","DOI":"10.1016\/j.metop.2020.100038","volume":"7","author":"M Rigo","year":"2020","unstructured":"Rigo, M. et al. Skin autofluorescence, a marker of glucose memory in type 2 diabetes. Metabol. Open 7, 100038. https:\/\/doi.org\/10.1016\/j.metop.2020.100038 (2020).","journal-title":"Metabol. Open"},{"key":"31845_CR47","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1186\/s12872-021-02303-z","volume":"21","author":"M Miyoshi","year":"2021","unstructured":"Miyoshi, M. et al. Significance of day-to-day glucose variability in patients after acute coronary syndrome. BMC Cardiovasc. Disord. 21, 490. https:\/\/doi.org\/10.1186\/s12872-021-02303-z (2021).","journal-title":"BMC Cardiovasc. Disord."},{"key":"31845_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s13340-022-00608-8","volume":"14","author":"E Aoki","year":"2022","unstructured":"Aoki, E. et al. Clinical significance of skin autofluorescence for diabetic macroangiopathy and comparison with conventional markers of atherosclerosis: a cross-sectional and prospective study. Diabetol. Int. 14, 145\u2013154. https:\/\/doi.org\/10.1007\/s13340-022-00608-8 (2022).","journal-title":"Diabetol. Int."},{"key":"31845_CR49","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1177\/0300060517736914","volume":"46","author":"F Isami","year":"2018","unstructured":"Isami, F., West, B. J., Nakajima, S. & Yamagishi, S. I. Association of advanced glycation end products, evaluated by skin autofluorescence, with lifestyle habits in a general Japanese population. J. Int. Med. Res. 46, 1043\u20131051. https:\/\/doi.org\/10.1177\/0300060517736914 (2018).","journal-title":"J. Int. Med. Res."},{"key":"31845_CR50","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.diabres.2018.02.017","volume":"139","author":"M Ohara","year":"2018","unstructured":"Ohara, M. et al. Improvements of ambient hyperglycemia and glycemic variability are associated with reduction in oxidative stress for patients with type 2 diabetes. Diabetes Res Clin Pract 139, 253\u2013261. https:\/\/doi.org\/10.1016\/j.diabres.2018.02.017 (2018).","journal-title":"Diabetes Res Clin Pract"},{"key":"31845_CR51","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1089\/dia.2023.0070","volume":"25","author":"KK Golla","year":"2023","unstructured":"Golla, K. K. et al. Comparison of accuracy of freestyle libre pro and medtronic Ipro2 continuous glucose monitoring systems in pregnancy. Diabetes Technol Ther. 25, 538\u2013542. https:\/\/doi.org\/10.1089\/dia.2023.0070 (2023).","journal-title":"Diabetes Technol Ther."},{"key":"31845_CR52","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes\u20142025. Diabetes Care. 2025;48 S128\u2013S145. https:\/\/doi.org\/10.2337\/dc25-s006","DOI":"10.2337\/dc25-s006"},{"key":"31845_CR53","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12933-018-0743-7","volume":"17","author":"D Matsutani","year":"2018","unstructured":"Matsutani, D. et al. Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes. Cardiovasc Diabetol 17, 100. https:\/\/doi.org\/10.1186\/s12933-018-0743-7 (2018).","journal-title":"Cardiovasc Diabetol"},{"key":"31845_CR54","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.clinbiochem.2004.09.016","volume":"38","author":"WJ Schnedl","year":"2005","unstructured":"Schnedl, W. J., Lahousen, T., Wallner, S. J., Krause, R. & Lipp, R. W. Silent hemoglobin variants and determination of HbA1c with the high-resolution program of the HPLC HA-8160 hemoglobin analyzer. Clin Biochem. 38, 88\u201391. https:\/\/doi.org\/10.1016\/j.clinbiochem.2004.09.016 (2005).","journal-title":"Clin Biochem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31845-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31845-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31845-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:34:41Z","timestamp":1768480481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31845-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["31845"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31845-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"28 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MO has received lecture fees from Eli Lilly Japan K.K. YM holds an endowed chair funded by Nippon Boehringer Ingelheim Co., Ltd. SY has received lecture fees from Bayer Yakuhin, Ltd., Kowa Company, Ltd., and Novo Nordisk Pharma, Ltd. The other authors declare no financial or non-financial competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2055"}}